MacroGenics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 13.14 million compared to USD 26.01 million a year ago. Net income was USD 57.47 million compared to net loss of USD 41.3 million a year ago. Basic earnings per share from continuing operations was USD 0.93 compared to basic loss per share from continuing operations of USD 0.67 a year ago. Diluted earnings per share from continuing operations was USD 0.92 compared to diluted loss per share from continuing operations of USD 0.67 a year ago.
For the six months, revenue was USD 37.63 million compared to USD 37.11 million a year ago. Net income was USD 19.46 million compared to net loss of USD 107.75 million a year ago. Basic earnings per share from continuing operations was USD 0.31 compared to basic loss per share from continuing operations of USD 1.76 a year ago. Diluted earnings per share from continuing operations was USD 0.31 compared to diluted loss per share from continuing operations of USD 1.76 a year ago.